If you're one of the millions of people dealing with psoriatic arthritis, you know just how frustrating it can be. One day, ...

Vyne Therapeutics has dosed the first participant in a randomised Phase Ib clinical trial of VYN202, an oral treatment for moderate-to-severe plaque psoriasis. The double-blind, placebo-controlled ...